KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $25.7 million.

  • Medpace Holdings' Other Non-Current Assets rose 1157.67% to $25.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year increase of 1157.67%. This contributed to the annual value of $22.3 million for FY2024, which is 1087.71% down from last year.
  • Medpace Holdings' Other Non-Current Assets amounted to $25.7 million in Q3 2025, which was up 1157.67% from $23.8 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Other Non-Current Assets high stood at $25.7 million for Q3 2025, and its period low was $13.1 million during Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $20.8 million (2023), whereas its average is $20.3 million.
  • As far as peak fluctuations go, Medpace Holdings' Other Non-Current Assets soared by 9811.23% in 2021, and later tumbled by 1711.51% in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Other Non-Current Assets stood at $17.4 million in 2021, then rose by 21.28% to $21.1 million in 2022, then increased by 18.18% to $25.0 million in 2023, then dropped by 10.88% to $22.3 million in 2024, then increased by 15.59% to $25.7 million in 2025.
  • Its last three reported values are $25.7 million in Q3 2025, $23.8 million for Q2 2025, and $21.5 million during Q1 2025.